(Q34346620)

English

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Jerling M

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Merlé Y

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mentré F

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mallet A

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 November 1994

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

453-462

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A pharmacokinetic perspective on medicament noncompliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

The importance of modeling interoccasion variability in population pharmacokinetic analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

The use of therapeutic drug monitoring data to document kinetic drug interactions: an example with amitriptyline and nortriptyline.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single-dose plasma-level data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Plasma-nortriptyline levels in endogenous depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Inhibitory effects of neuroleptics on debrisoquine oxidation in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Substantial rise in sparteine metabolic ratio during haloperidol treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Disposition of the neuroleptic zuclopenthixol cosegregates with the polymorphic hydroxylation of debrisoquine in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Kinetics of nortriptyline in man according to a two compartment model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Individual Differences in the Disposition of Drugs Metabolised in the Body

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

6 July 2018

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04382.X

21 January 2018

Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364880

27 October 2018

Nortriptyline response in elderly depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels and effects of nortriptyline in geriatric depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady state pharmacokinetics of nortriptyline in the frail elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in Man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nortriptyline plasma levels and therapeutic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and the effects of nortriptyline in geriatric depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of nortriptyline in elderly volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

d-Propoxyphene is a potent inhibitor of debrisoquine, but not S-mephenytoin 4-hydroxylation in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Debrisoquine oxidation phenotype during neuroleptic monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

1 reference

https://pubmed.ncbi.nlm.nih.gov/7893588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1994.TB04382.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34346620&oldid=1607372701"